Literature DB >> 15645288

Expression of homeodomain protein CDX2 in gallbladder carcinomas.

Xiang-Song Wu1, Yoshimitsu Akiyama, Toru Igari, Tohru Kawamura, Susumu Hiranuma, Toshikatsu Shibata, Kouji Tsuruta, Morio Koike, Shigeki Arii, Yasuhito Yuasa.   

Abstract

PURPOSE: Caudal-related homeobox protein CDX2 plays an important role in the regulation of cell proliferation and differentiation of the intestinal epithelium. CDX2 is associated with intestinal metaplasia and carcinomas of the stomach, but the role of CDX2 in gallbladder carcinogenesis remains unknown.
METHODS: We analyzed the expression of CDX2 and intestinal apomucin MUC2 in gallbladder cancer cell lines at the mRNA level by the RT-PCR method. We also investigated the expression of CDX2 and MUC2 in 68 primary gallbladder carcinomas by the immunohistochemical staining method and compared the expression of CDX2 with the clinicopathological factors in the gallbladder carcinoma cases.
RESULTS: Expression of CDX2 and MUC2 was found in three of four gallbladder cancer cell lines at the mRNA level. In addition, we found that CDX2 was absent in the normal gallbladder epithelium, but the CDX2 protein was expressed in 25 of the 68 (36.8%) gallbladder carcinomas. Interestingly, in the tubular type gallbladder carcinomas, the frequency of CDX2 expression was much higher in the well-differentiated type than the moderately and poorly differentiated types, the difference being statistically significant (P<0.01). CDX2 expression showed a relationship with expression of MUC2 (P<0.04) in the gallbladder carcinomas. CDX2 was expressed in intestinal metaplasia and dysplasia, which are hypothesized to be premalignant conditions.
CONCLUSION: These results imply that CDX2 plays an important role in gallbladder carcinogenesis with intestinal differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645288     DOI: 10.1007/s00432-004-0658-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  40 in total

1.  Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression.

Authors:  Hiroshi Yamamoto; Yun Qing Bai; Yasuhito Yuasa
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

2.  Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression.

Authors:  I Roa; J C Araya; M Villaseca; X De Aretxabala; P Riedemann; K Endoh; J Roa
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody.

Authors:  C A Reis; L David; P A Nielsen; H Clausen; K Mirgorodskaya; P Roepstorff; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

4.  Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesions to gastric carcinoma.

Authors:  M I Filipe; J M Linehan; L G Durrant; M R Price; N C Smeeton; S Pathak; D M Swallow
Journal:  Eur J Cancer Prev       Date:  1996-08       Impact factor: 2.497

5.  K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.

Authors:  Asif Rashid; Takashi Ueki; Yu-Tang Gao; Patrick Scott Houlihan; Charita Wallace; Bing-Sheng Wang; Ming-Chang Shen; Jie Deng; Ann W Hsing
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

Review 6.  Gallbladder cancer.

Authors:  L G Dawes
Journal:  Cancer Treat Res       Date:  2001

7.  Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.

Authors:  Roy W Phillips; Henry F Frierson; Christopher A Moskaluk
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

Review 8.  Control of gut differentiation and intestinal-type gastric carcinogenesis.

Authors:  Yasuhito Yuasa
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

9.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Authors:  Akashi Eda; Hiroyuki Osawa; Kiichi Satoh; Ichiro Yanaka; Ken Kihira; Yumiko Ishino; Hiroyuki Mutoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

10.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  11 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.

Authors:  Artit Jinawath; Yoshimitsu Akiyama; Yasuhito Yuasa; Chawalit Pairojkul
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-23       Impact factor: 4.553

3.  Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.

Authors:  Yoji Wani; Kenji Notohara; Masayoshi Fujisawa
Journal:  Virchows Arch       Date:  2008-10-09       Impact factor: 4.064

Review 4.  "Pure" High-Grade Large Cell Neuroendocrine Carcinoma Arising from Low- and High-Grade Dysplasia of the Gallbladder: Case Report and Review of the Literature.

Authors:  Cacey Peters; Eleanor Lewin; Tong Wu; Yukihiro Nakanishi
Journal:  J Gastrointest Cancer       Date:  2019-12

5.  Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis.

Authors:  C Maesawa; S Ogasawara; A Yashima-Abo; T Kimura; K Kotani; S Masuda; Y Nagata; T Iwaya; K Suzuki; T Oyake; Y Akiyama; H Kawamura; T Masuda
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

6.  Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression.

Authors:  Yasuyo Tani; Yoshimitsu Akiyama; Hiroshi Fukamachi; Kazuyoshi Yanagihara; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-28       Impact factor: 4.553

7.  The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.

Authors:  Haowen Tang; Zhanbo Wang; Wenping Lv; Xuan Meng
Journal:  Intractable Rare Dis Res       Date:  2018-05

8.  Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.

Authors:  Qing-Long Li; Zhu-Lin Yang; Jie-Qiong Liu; Xiong-Ying Miao
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

9.  The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry.

Authors:  Byoung Hwan Lee; Nayoung Kim; Hye Seung Lee; Jung Mook Kang; Hyun Kyung Park; Hyun Jun Jo; Cheol Min Shin; Sang Hyub Lee; Young Soo Park; Jin Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

Review 10.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.